These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 1964495)
1. [Tumor markers. I. Their significance in the preoperative assessment of lung neoplasms]. Ratto GB; Capponi G; De Grandi R; Augeri C; Secco GB; Fardelli R Minerva Chir; 1990 Oct; 45(20):1265-72. PubMed ID: 1964495 [TBL] [Abstract][Full Text] [Related]
2. [Tumor markers. II. Their significance in the follow-up of patients after radical resection of lung neoplasms]. Ratto GB; Capponi G; De Grandi R; Augeri C; Secco GB; Fardelli R Minerva Chir; 1990 Oct; 45(20):1273-80. PubMed ID: 2082204 [TBL] [Abstract][Full Text] [Related]
3. Multiple tumour markers for diagnosis, management and follow-up of potentially resectable lung cancer. Ratto GB; Mereu C; Rovida S Panminerva Med; 1993 Dec; 35(4):186-92. PubMed ID: 8202329 [TBL] [Abstract][Full Text] [Related]
4. [The diagnostic values of CA242 combining other tumor markers for lung cancer]. Zhang S; Ma Y; Yang X Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):271-3. PubMed ID: 11775851 [TBL] [Abstract][Full Text] [Related]
5. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer]. Pan QR; Zhang X; Xu ZF; Zheng S Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076 [TBL] [Abstract][Full Text] [Related]
6. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE]. Prévost A; Passemard F; Perdu D; Vallerand H; Deschamps F; Lavaud F; Larbre H Rev Mal Respir; 1994; 11(4):379-84. PubMed ID: 7973038 [TBL] [Abstract][Full Text] [Related]
7. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study. Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259 [TBL] [Abstract][Full Text] [Related]
8. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer. Foa P; Fornier M; Miceli R; Seregni E; Santambrogio L; Nosotti M; Cataldo I; Sala M; Caldiera S; Bombardieri E Anticancer Res; 1999; 19(4C):3613-8. PubMed ID: 10629660 [TBL] [Abstract][Full Text] [Related]
9. [Tissue polypeptide antigen in serum and tissue in patients with lung cancer]. Haga E Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr; 28(4):595-604. PubMed ID: 2170727 [TBL] [Abstract][Full Text] [Related]
10. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients. Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320 [TBL] [Abstract][Full Text] [Related]
11. [Comparative analysis of serum levels of CA-50, CA-125, CA-19.9, enolase and CEA in bronchopulmonary cancer]. Maréchal F; Deltour G; Incatasciato C; Carpentier Y; Cattan A Rev Pneumol Clin; 1987; 43(5):224-8. PubMed ID: 2829332 [TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of pleural effusion carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific-enolase in patients with lung cancer]. Fujii M; Kiura K; Kamei H; Segawa Y Nihon Kyobu Shikkan Gakkai Zasshi; 1988 May; 26(5):519-23. PubMed ID: 2852270 [No Abstract] [Full Text] [Related]
13. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer]. Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108 [TBL] [Abstract][Full Text] [Related]
14. [Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer]. Yano H; Hino M; Nishiwaki Y; Kodama T; Hayashibe A; Kudo H; Inoue Y; Nishiyama Y; Sone Y; Oshima T Gan To Kagaku Ryoho; 1987 Jan; 14(1):77-83. PubMed ID: 3026257 [TBL] [Abstract][Full Text] [Related]
15. [Measurement of carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific enolase in the bronchoalveolar lavage fluid in patients with peripheral lung cancer]. Fujii M; Kiura K; Kamei H; Segawa Y Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr; 27(4):452-5. PubMed ID: 2552209 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer. Nikliński J; Chyczewska E; Furman M; Kowal E; Laudanski J; Chyczewski L Neoplasma; 1993; 40(5):305-8. PubMed ID: 8272160 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions. Miédougé M; Rouzaud P; Salama G; Pujazon MC; Vincent C; Mauduyt MA; Reyre J; Carles P; Serre G Br J Cancer; 1999 Nov; 81(6):1059-65. PubMed ID: 10576665 [TBL] [Abstract][Full Text] [Related]
18. [Tumor marker in lung cancer]. Shijubo N; Abe S Kokyu To Junkan; 1993 Jun; 41(6):551-5. PubMed ID: 7687790 [No Abstract] [Full Text] [Related]
19. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases. Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318 [TBL] [Abstract][Full Text] [Related]
20. Values and limits of combined use of 4 tumor markers (CEA, TPA, NSE and SCC) in un-treated patients with lung cancer. Cuomo A; Capra R; Greco S; Cacciani GC; Greco F; Franchini D; Bonelli P; Gavaruzzi G; Ugolotti G Acta Biomed Ateneo Parmense; 1993; 64(5-6):171-84. PubMed ID: 7992555 [No Abstract] [Full Text] [Related] [Next] [New Search]